Stock 688193 SHANGHAI RENDU BIOTECHNOLOGY CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News Shanghai Rendu Biotechnology Co., Ltd.

Equities

688193

CNE1000059K5

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-07-15 pm EDT 		5-day change 1st Jan Change
25 CNY -0.99% Intraday chart for Shanghai Rendu Biotechnology Co., Ltd. -3.55% -44.59%
Apr. 29 Shanghai Rendu Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 02 Tranche Update on Shanghai Rendu Biotechnology Co., Ltd.'s Equity Buyback Plan announced on February 19, 2024. CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Shanghai Rendu Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Tranche Update on Shanghai Rendu Biotechnology Co., Ltd.'s Equity Buyback Plan announced on February 19, 2024.
CI
Shanghai Rendu Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Shanghai Rendu Biotechnology Co., Ltd. announces an Equity Buyback for CNY 50 million worth of its shares.
CI
Shanghai Rendu Biotechnology Co., Ltd. authorizes a Buyback Plan.
CI
Shanghai Rendu Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Shanghai Rendu Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Shanghai Rendu Biotechnology Gets Certificate for Registration of HIV Kit
MT
Shanghai Rendu Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Shanghai Rendu Biotechnology Co., Ltd.(SHSE:688193) added to Shanghai Stock Exchange Composite Index
CI
Shanghai Rendu Biotechnology Co., Ltd.(SHSE:688193) added to Shanghai Stock Exchange A Share Index
CI
Shanghai Rendu Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Shanghai Rendu Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
Shanghai Rendu Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
Coland Holdings Limited cancelled the acquisition of an unknown stake in Shanghai Rendu Biotechnology Co., Ltd.
CI
Coland Holdings Limited agreed to acquire an unknown stake in Shanghai Rendu Biotechnology Co., Ltd. for TWD 180 million.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 688193 Stock
  4. News Shanghai Rendu Biotechnology Co., Ltd.